Concepedia

Prithviraj Bose

PB

Statistics

Publications

144

Citations

6.7K

H-Index

45

Active since

2010

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Virginia Commonwealth University

University of Michigan

Guy's and St Thomas' NHS Foundation Trust

Memorial Sloan Kettering Cancer Center

Prithviraj Bose is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, oncology, and hematology.

ORCID

Top concepts

Publications per year

2010–2025

144

Publications

144

Ibrutinib and Venetoclax for First-Line Treatment of CLL

Nitin Jain, Michael J. Keating, Philip A. Thompson et al. · New England Journal of Medicine · 2019 · 491 citations · Full text

Complex I inhibitor of oxidative phosphorylation in advanced solid tumors and acute myeloid leukemia: phase I trials

Timothy A. Yap, Naval Daver, Mikhila Mahendra et al. · Nature Medicine · 2023 · 335 citations · Full text

, , +8

10-day decitabine with venetoclax for newly diagnosed intensive chemotherapy ineligible, and relapsed or refractory acute myeloid leukaemia: a single-centre, phase 2 trial

Courtney D. DiNardo, Abhishek Maiti, Caitlin R. Rausch et al. · The Lancet Haematology · 2020 · 325 citations · Full text

, , +9

Clonal evolution and outcomes in myelofibrosis after ruxolitinib discontinuation

Kate J. Newberry, Keyur P. Patel, Lucia Masárová et al. · Blood · 2017 · 210 citations · Full text

Safety and efficacy of avapritinib in advanced systemic mastocytosis: the phase 1 EXPLORER trial

Daniel J. DeAngelo, Deepti Radia, Tracy I. George et al. · Nature Medicine · 2021 · 139 citations · Full text

1–5 of 144